These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33914734)

  • 1. Mapping the degradation pathway of a disease-linked aspartoacylase variant.
    Gersing SK; Wang Y; Grønbæk-Thygesen M; Kampmeyer C; Clausen L; Willemoës M; Andréasson C; Stein A; Lindorff-Larsen K; Hartmann-Petersen R
    PLoS Genet; 2021 Apr; 17(4):e1009539. PubMed ID: 33914734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of aspartoacylase: implications for Canavan disease.
    Hershfield JR; Pattabiraman N; Madhavarao CN; Namboodiri MA
    Brain Res; 2007 May; 1148():1-14. PubMed ID: 17391648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.
    Kaul R; Balamurugan K; Gao GP; Matalon R
    Genomics; 1994 May; 21(2):364-70. PubMed ID: 8088831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.
    Zeng BJ; Wang ZH; Ribeiro LA; Leone P; De Gasperi R; Kim SJ; Raghavan S; Ong E; Pastores GM; Kolodny EH
    J Inherit Metab Dis; 2002 Nov; 25(7):557-70. PubMed ID: 12638939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Eke GH; Iscan A; Cece H; Calik M
    Genet Couns; 2012; 23(1):9-12. PubMed ID: 22611636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chaperone-assisted protein aggregate reactivation: Different solutions for the same problem.
    Aguado A; Fernández-Higuero JA; Moro F; Muga A
    Arch Biochem Biophys; 2015 Aug; 580():121-34. PubMed ID: 26159839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
    Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B
    J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular chaperones of the Hsp110 family act as nucleotide exchange factors of Hsp70s.
    Dragovic Z; Broadley SA; Shomura Y; Bracher A; Hartl FU
    EMBO J; 2006 Jun; 25(11):2519-28. PubMed ID: 16688212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp70-Hsp110 chaperones deliver ubiquitin-dependent and -independent substrates to the 26S proteasome for proteolysis in yeast.
    Kandasamy G; Andréasson C
    J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29507114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate binding by the yeast Hsp110 nucleotide exchange factor and molecular chaperone Sse1 is not obligate for its biological activities.
    Garcia VM; Nillegoda NB; Bukau B; Morano KA
    Mol Biol Cell; 2017 Jul; 28(15):2066-2075. PubMed ID: 28539411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel aspartoacylase (ASPA) gene mutation in Canavan disease.
    Durmaz AA; Akin H; Onay H; Vahabi A; Ozkinay F
    Fetal Pediatr Pathol; 2012 Aug; 31(4):236-9. PubMed ID: 22468686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Type II Hsp40 Sis1 cooperates with Hsp70 and the E3 ligase Ubr1 to promote degradation of terminally misfolded cytosolic protein.
    Summers DW; Wolfe KJ; Ren HY; Cyr DM
    PLoS One; 2013; 8(1):e52099. PubMed ID: 23341891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated Hsp110 and Hsp104 Activities Power Protein Disaggregation in Saccharomyces cerevisiae.
    Kaimal JM; Kandasamy G; Gasser F; Andréasson C
    Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28289075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp70 nucleotide exchange factor Fes1 is essential for ubiquitin-dependent degradation of misfolded cytosolic proteins.
    Gowda NK; Kandasamy G; Froehlich MS; Dohmen RJ; Andréasson C
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5975-80. PubMed ID: 23530227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial sequestration of misfolded proteins as an active chaperone-mediated process during heat stress.
    Boronat S; Cabrera M; Hidalgo E
    Curr Genet; 2021 Apr; 67(2):237-243. PubMed ID: 33386485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperone-Mediated Protein Disaggregation Triggers Proteolytic Clearance of Intra-nuclear Protein Inclusions.
    den Brave F; Cairo LV; Jagadeesan C; Ruger-Herreros C; Mogk A; Bukau B; Jentsch S
    Cell Rep; 2020 Jun; 31(9):107680. PubMed ID: 32492414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease.
    Mersmann N; Tkachev D; Jelinek R; Röth PT; Möbius W; Ruhwedel T; Rühle S; Weber-Fahr W; Sartorius A; Klugmann M
    PLoS One; 2011; 6(5):e20336. PubMed ID: 21625469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartoacylase gene knockout results in severe vacuolation in the white matter and gray matter of the spinal cord in the mouse.
    Surendran S; Campbell GA; Tyring SK; Matalon R
    Neurobiol Dis; 2005 Mar; 18(2):385-9. PubMed ID: 15686967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of the Yeast Hsp31 Chaperones of the DJ-1 Superfamily Perturbs Cytoplasmic Protein Quality Control in Late Growth Phase.
    Amm I; Norell D; Wolf DH
    PLoS One; 2015; 10(10):e0140363. PubMed ID: 26466368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of aspartoacylase (ASPA) and Canavan disease.
    Sommer A; Sass JO
    Gene; 2012 Sep; 505(2):206-10. PubMed ID: 22750302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.